(Q63405227)
Statements
A Phase 3 Study of Erdafitinib Compared With Vinflunine or Docetaxel or Pembrolizumab in Subjects With Advanced Urothelial Cancer and Selected FGFR Gene Aberrations (English)
0 references
23 March 2018
0 references
24 November 2020
0 references
631
0 references
18 year
0 references